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Cognitive-Behavioral Group Therapy for Irritable Bowel Syndrome: Effects and 
Long-Term Follow-Up
A. M. v a n  D u l m e n , MA, J. F .  M. F e n n i s , MD, PhD, a n d  G. B l e i j e n b e r g , PhD
Little is k n o w n  about  the  effectiveness of cognitive-behavioral t rea tm ent  for pa t ien ts  w i th  irritable bowel 
syndrome on a group basis. P rev ious  s tudies  have  u sed  only small samples ,  and  s tud ies  w ith  long term 
follow-up are lacking. T he  a im  of th e  p resen t  s tudy  was to investigate: a) the  effectiveness of a cognitive- 
behavioral group t rea tm ent  co m p ared  w i th  a w ait ing  list control  cond i t ion  in  alleviating abdominal 
complaints a n d  b) th e  long te rm  effectiveness of cognitive-behavioral group treatment» In s tudy 1 , we 
performed a contro lled  s tudy  w i th  25 patien ts  in  the group trea tment cond i t ion  a n d  20 pa t ien ts  in  the waiting 
list control condit ion .  T rea tm en t  consis ted  of eight 2-hour group sessions over a p e r io d  of 3 months .  In study
2, all patients w ere  t rea ted  a n d  followed up  for a n  average of 2.25 years (range 6 m o n th s -4  years) after the 
completion of the group  trea tm ent.  The abdom ina l  com pla in ts  of the  pa tien ts  w h o  u n d e r w e n t  treatment were 
found to improve significantly  m ore  th an  the  com pla in ts  of the pa tien ts  await ing  t rea tm ent ,  Moreover, in 
agreement w ith  the  p u rp o se  of the therapy, the  n u m b e r  of  successful coping strategies w as  fo und  to increase 
more and pa t ien ts ’ avo idance  behav io r  w as  found  to decrease more in  the t rea tm en t  g rou p  th a n  in  the waiting 
list control group. The  posit ive  changes appeared  to persis t  during  follow-up. Cognitive-behavioral group 
treatment is effective i n  alleviating irritable bow e l  syndrom e,  in  s t im ula t ing  cop ing  strategies, and  in  reducing 
avoidance behavior.  A t  long te rm  follow-up, the abdom inal  complaints ,  the  n u m b e r  of successful coping 
strategies, and the avo idance  behav io r  w ere  still im p ro v ed  com pared  w ith  the  p re t rea tm en t  assessment,
Key words: cognitive-beh avi oral group therapy, contro lled  s tudy, coping, irritable b o w e l  syndrom e, long-term 
follow-up.
INTRODU CTION
Abdominal complaints have a high prevalence in 
the general population and are associated with a 
high rate of medical visits (1). Sixteen percent of the 
patients attending a general practitioner with ab­
dominal complaints are referred for extensive phys­
ical examination, most often to internal medicine 
(2). In the majority of referred cases, no somatic 
explanation can be found (3, 4). These so-called 
functional abdominal complaints can also be re­
ferred to as irritable bowel syndrome, of which two 
definitions are known based on broad (5) and restric­
tive criteria (6), respectively. Irritable bowel syn­
drome appears to have a poor prognosis (7-9). Stan­
dard medical treatments, such as medication and
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dietary advice, are rather ineffective in improving 
this prognosis (10, 11).
Recently, we found, at an outpatient internal med­
icine clinic, that, during medical consultations, doc­
tors are able to influence complaint-related cogni­
tions and that these achieved changes are related to 
improvement of irritable bowel symptoms at fol- 
low-up (9, 12). Thus, at least some patients with 
irritable bowel syndrome can be treated successfully 
during medical consultations with minimal psycho­
logical intervention. Patients who did not improve 
or improved less after the consultations appeared to 
report more somatic attributions and catastrophizing 
cognitions as well as less psychological attributions 
and self-efficacy expectations (9). For these patients 
with severe and chronic complaints, referral to a 
behavior therapist may be indicated.
Psychotherapeutic treatment programs adminis­
tered individually have shown to be effective in 
alleviating irritable bowel syndrome (13-20). How­
ever, given the large numbers of patients with irrita­
ble bowel syndrome and the general concern with 
cost containment in health care, it seems worthwhile 
to establish the effects of cognitive-behavioral group 
treatment. The first uncontrolled study in which the 
effectiveness of behavioral group therapy was eval­
uated was reported by Wise et al. in 1982 (21). After 
group treatment, one-third of a group of 20 treated 
patients reported a reduction of their abdominal
Psychosomatic Medicine 58:508-514 (1996)
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complaints. Positive results were also reported by 
Blanchard and Schwarz who evaluated the short 
term effects of cognitive-behavioral group treatment 
011 three groups with a total of 14 patients (22). This 
group treatment was an adaptation of their behav­
ioral treatment program administered individually 
(16). These uncontrolled studies suggest that cogni­
tive-behavioral group treatment is effective in allevi­
ating abdominal complaints. Long term effects of 
cognitive-behavioral group treatment are not known. 
The aim of the present study was to investigate the 
effectiveness of group treatment compared with a 
waiting list control group (study 1) as well as the 




Subjects. Forty-seven outpatients with, refractory irritable 
bowel syndrome were recruited by the Outpatient University 
Clinic for Internal Medicine for cognitive-behavioral group treat­
ment. Irritable bowel syndrome was broadly defined as abdominal 
pain with or without disordered defecation with a duration of at 
least 3 months in the absence of any recognized gastrointestinal 
pathology (5); the abdominal pain-predominant patients were 
considered to have refractory irritable bowel syndrome when they 
had not responded to the outpatient standard approach, reassur­
ance and education, for patients with irritable bowel syndrome 
[13,23). Patients were allocated to the treatment condition, which  
was presented as “a course in  coping with abdominal complaints” 
until the first group was full, and then the next patients were put 
on the waiting list until a new  group began. Ultimately, seven  
groups were completed. To restrict the duration of the waiting 
period, each group consisted partly of patients from the waiting 
list and partly of recently referred patients. The treatment condi­
tion consisted of 27 patients, 16 wom en and 11 men, with a mean 
age of 44 (SD = 1 1 ) years and a mean duration of abdominal 
complaints of 5.0 (SD = 4.2) years, The waiting list control group 
consisted of 2 0  patients, 8  w om en and 1 2  men, with a mean age of 
48 (SD = 14) years and a mean duration of complaints of 5.3 (SD = 
4.0) years. The mean duration of the waiting period was 3.5 
months (SD -  1.5), w hich was about the same duration as the 
group treatment. During treatment and waiting period, no con­
comitant somatic treatment was given, Two patients in the treat­
ment condition returned incom plete questionnaires, so the effects 
of the group treatment could only be evaluated in 25 patients.
Group Treatment A ll patients underwent the same treatment, 
which consisted of eight 2-hour group sessions over a period of 3 
months. An experienced psychotherapist and a junior psycholo­
gist conducted all sessions, aim ed at modifying maladaptive 
cognitions and behavior and stimulating different and more 
effective ways of coping w ith the complaints. The group treatment 
was based on principles from cognitive-behavioral treatment (24, 
25) and combined:
1 . Patient education about the role of cognitions, behavior, emo­
tions, and environment in relation to the abdominal com­
plaints, Attention was given to correction of unjustified or
dysfunctional attributions, to events or circumstances preced­
ing or following the presence of complaints, and to reactions, 
in thinking, feeling, or behavior, to the presence of complaints.
2 . Homework. Patients were stimulated to change their com ­
plaint-related cognitions and behavior and to try out new  ways 
of thinking and behaving between sessions. The patients de­
scribed their experiences in a diary.
3. Group conversation. During the sessions, m uch time was spent 
talking about the educational part and the patients1 experi­
ences with the homework. Attention was given to mutual 
recognition of the problems the participants had in coping with  
their pain.
4. Training in progressive m uscle relaxation. Each session was 
concluded by a muscle relaxation exercise (26), Patients were 
instructed how  to use these exercises at home and in daily life. 
Later on, coping imagery exercises were added.
The information that was presented during each session, the 
relaxation instructions, and the homework were also given in  
written form as a course book. Themes of the sessions were: “1 . 
General introduction 2 . Cognitions and abdominal pain 3. Chang­
ing cognitions 4. Discovering antecedent cognitions and behavior
5. Changing behavior 6 . Role of environment 7, Changing com ­
plaint-related lifestyle 8 . Coping in the future.”
Assessment Patients completed the following questionnaires 
at first and second assessment: patients in the treatment group 
before and after the completion of the treatment and patients in 
the waiting list control group before and after the waiting period: 
Diary. The Daily Abdominal Complaint Score (DAC) was 
measured using a prescheduled diary in w hich patients rated 
their abdominal pain through self-observation four times daily 
during 2 weeks on a scale from 0 (no pain) to 4 (serious interfering 
pain). Thus the DAC score could vary between 0 and 16 (27, 28). 
This score is reliable and able to measure change (28).
Daily duration of the abdominal pain was also measured by 
means of the diary in w hich patients reported four times daily 
how long they had experienced abdominal pain since the last 
measurement Scores ranged from 0  (0  hours), 1 (less than 2 
hours), 3 (more than 2 hours but less than 4 hours), to 5 (more than 
4 hours). Scores at breakfast were doubled because at that time 
ratings were based on the preceding night, a period tw ice as long 
as the intervals between consecutive ratings in the daytime. So the 
daily duration of the abdominal pain could vary between 0 and 25 
(27, 28).
Daily avoidance behavior was measured using the above m en­
tioned diary in w hich patients reported four times daily whether 
or not they had avoided certain activities because of the abdom­
inal pain since their last observation. An individual avoidance 
score was presented as a percentage, indicating the number of 
times the patient reported avoidance, divided by the total number 
of observations during the 2 weeks.
Finally, in the diary, patients reported four times daily whether 
they had suffered from the following gastrointestinal complaints: 
flatulence, belching, nausea, heartburn, abdominal rumbling. De­
tails of the defecation were also noted: difficult or painful evac­
uation, a feeling of incom plete evacuation, and the type of 
defecation (hard, w ell formed, or pulpy stools).
Abdominal Complaint Inventory. In the abdominal com plaint 
inventory, biographical data, history, and details of the com ­
plaints as well as coping strategies and use of m edication for 
abdominal complaints were listed.
The severity score of the abdominal complaints (range 0 -9 )  
was determined by summing the reported frequency of the com ­
plaints (0-3), interference w ith daily activities (0 -3 ), and avoid­
ance behavior (0-3). A score of 0  refers to patients who experi­
enced abdominal complaints less than once a month without
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being bothered by these complaints, 9 to patients who reported 
daily complaints and much interference and avoidance behavior 
(7, 9).
The number of coping strategies patients used to cope with 
their complaints successfully was counted. For that purpose, 
patients were asked to indicate how many of 14 different ways of 
behaving or thinking (eg, relaxation excercises; avoiding certain 
foods or drinks; thinking that the complaints are bearable) most 
often resulted in experiencing less complaints. This list of coping 
strategies was adapted from the Pain Coping Inventory, a reliable 
3 3-item scale referring to the patient’s use of cognitive and 
instrumental strategies when in  pain (29).
Psychological Well Being. The Symptom Check List (SCL-90) 
was used as a parameter for psychological w ell being; the total 
score was used (30). A high score reflects a decreased level of 
psychological well being.
Outcome Measures. Following its purpose, treatment was eval­
uated in terms of changes in Daily Abdominal Complaint score 
(DAC), daily duration of the pain, daily avoidance, severity score, 
number of successful coping strategies, and psychological w ell 
being, Moreover, DAC scores were used to assess the outcome of 
treatment on an individual subject basis by calculating the per­
centage change for each patient. A patient was defined as clin i­
cally improved when the DAC score had decreased 50% or more 
(31).
Statistics. Differences between subgroups of patients were 
investigated using the Mann-Whitney U and x 2 tests. For each 
patient, a change score was calculated by subtracting scores at 
second assessment from baseline scores. Using these change 
scores, it was possible to compare the amount of changes in 
treated patients and controls using Mann-Whitney U and inde­
pendent t tests (for the number of coping strategies). Statistical 
significance for all tests was set at the 5 % level.
Results
Treatment Group vs. Waiting List Control Group at 
Baseline. No significant differences emerged among 
the baseline scores on demographic and symptom 
measures between treatment group [N = 27) and 
control group [N = 20). Moreover, no baseline dif­
ferences emerged among the number of successful 
coping strategies, daily avoidance behavior, and the 
level of psychological well being. So both groups 
appeared to be well matched.
Changes Between First and Second Assessment. 
Table 1 presents the means on the DAC score, daily 
duration, daily avoidance, severity score, number of 
successful coping strategies, and psychological well 
being at first and second assessment for treated 
patients and controls. Patients’ DAC score, daily 
duration, daily avoidance, and number of successful 
coping strategies appeared to improve significantly 
more during the group treatment than during the 
waiting period. No significant differences were 
found comparing improvement in the level of psy­
chological well being or in any of the secondary 
gastrointestinal complaints.
The mean decrease in the DAC score for all pa-
TABLE 1 . Mean Scores on Complaints, Daily Avoidance, 
Number of Successful Coping Strategies, and Psychological 
Well Being at First and Second Assessm ent for Treatment (T) 
[N =  25) and Control Group (C) [N  = 2 0 ) with Level of 
Significance of the Difference in  Change Scores
First Assessment Second Assess­
P(M (SD)) ment (M (SD))
Diary3
DAC score T 5.66 (2.77) 3.68 (3.35)b
.002
C 4.81 (2.64) 5.41 (3.46)
Daily duration T 10.90 (6.29) 6.77 (6.60)b
.047
C 10,80 (7.66) 10,73 (7,71)
Daily avoidance T 19.17 (28.88) 17,39 (29.32)b
.003
C 14.03 (20.43) 21.94 (27.61 )b
Inventory
Severity score T 5.40 (1.75) 4.76 (2.09)
.090
C 4.85 (1.90) 5.00 (2.20)




C 2.50 (2.61) 2.70 (2.08)
Psychological well T 156 (49.60) 147 (54.18)
being
.37
C 152 (43.20) 153 (46.11)
aThe prescheduled diary was completed by 24 patients in the 
treatment condition and 18 controls.
b Significant within group changes between consecutive assessments.
tients in the treatment group was 37% (SD = 40); all 
controls showed a mean increase of 22% (SD = 80). 
This difference was statistically significant [p = 
.005). Forty-four percent of the patients in the treat­
ment group and 11% of the controls showed a 
decrease in the DAC score of more than 50% [p = 
.02). Moreover, in the treatment and control groups, 
no differences were found in the mean change in the 
DAC score between female and male patients.
Treatment of Waiting List Controls. Eighteen of the 
20 patients from the waiting list control group sub­
sequently underwent group treatment. During this 
group treatment, the DAC score of these patients 
decreased, with an average of 23% (SD = 40), not 
significantly different from the original treatment 
group [p = .26).
Two patients refused the offered treatment. The 
baseline scores from these two patients were within 
0.6 SD from the mean of the treated patients, except 
for psychological well being, which was found to be 
much lower in the two refusers.
Improvement in Psychological Well Being. Al­
though patients’ psychological well being did not 
appear to improve as a result of the group treatment,
510 Psychosomatic Medicine 58:508-514 (1996)
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improvement in psychological well being was found 
to correlate significantly with reductions in the daily 
abdominal complaint score (r = .46, p  = .002), daily 
duration (r = .35, p  = .01), and severity score (r =  
.46, p = .001) during treatment [N = 43).
STUDY 2
Metho ds
Subjects. A ll patients from study 1 ultimately received the 
sam e treatment, so we report the results of a long term follow-up 
study of both groups of patients together, Patients were asked to 
com plete questionnaires at several occasions after completing 
treatment, namely at 6 , 12, 24, 36, and 48 m onths posttreatment. 
Because not all patients had completed treatment at least 48 
months ago, follow-up points differed, Follow-up results were 
available for 32 patients from the 45 patients who underwent 
treatment; six  patients completed treatment but did not return the 
follow-up questionnaire; seven patients returned an incomplete 
follow -up questionnaire. The follow-up group consisted of 16 
w om en and 16 men. The mean length of tim e between completion 
o f the group treatment and follow-up assessm ent was 2.25 years 
(SD = 1.12) with a range from 6  months to 4 years. Twenty-seven 
patients completed the prescheduled diary during 2 weeks at 
follow-up.
Assessment at Follow-Up. At follow-up, patients completed the 
sam e instruments as described in study 1 . Data collected at the 
en d  of the waiting period were used as pretreatment measure­
m ents for the follow-up study of former controls,
Statistics. Changes in scores on complaints [DAC, duration, 
and severity), daily avoidance, and psychological w ell being 
betw een pretreatment and follow-up were measured using Wil­
coxon matched-pairs signed-ranks test. Changes in the number of 
coping strategies were measured using a paired t test. Change 
scores were calculated by subtracting the scores at follow-up from 
the scores at pretreatment and were used to compare the amount 
o f change in former controls and treated patients, in patients with  
a short and a long follow-up, and in female and male patients, by 
m eans of Mann-Whitney U test. Differences between subgroups of 
patients were investigated using Mann-Whitney U and x2 tests. 
Spearman rank correlation coefficients were used to investigate 
the relationships between improvement in the DAC score and the 
u se of medication and health care services at follow-up. Statistical 
significance was set at the 5 % level.
Results
Follow-Up Group vs. Missings. At baseline, the 32 
patients in the follow-up group and the 13 patients 
who did not return the follow-up questionnaire or 
filled it in incompletely were comparable with re­
spect to sex, age, duration of complaints before 
referral, and expectations regarding the treatment. 
Furthermore, no differences were found between 
both groups in the DAC score, daily duration of the 
abdominal pain, daily avoidance, severity score, 
number of successful coping strategies, or psycho­
logical well being immediately after treatment. Thus,
not returning the follow-up questionnaires did not 
appear to be related to differences in the treatment 
outcome. The five patients who did not complete the 
prescheduled diary at follow-up did not differ with 
respect to any of the above mentioned variables from 
the patients who completed the diary at follow-up.
Concomitant Treatment During Follow-Up. During 
follow-up, three patients from the original treatment 
condition and two patients from the waiting list 
received either individual cognitive-behavioral psy­
chotherapy or psychiatric treatment for problems 
that came up during the group therapy (posttraumat- 
ic stress disorders and obsessive-compulsive disor­
der, respectively). These five patients did not appear 
to improve more or less on any of the outcome 
measures from those not receiving concomitant psy­
chotherapeutic treatment.
Changes Between Pretreatment and Follow-Up. 
Table 2 shows the means on abdominal complaints, 
daily avoidance, number of successful coping strat­
egies, and psychological well being at pretreatment 
and at follow-up. The means on all outcome mea­
sures at follow-up were improved compared with 
the pretreatment means and reached conventional 
levels of significance [p < .05) on the DAC score, 
daily duration, daily avoidance, and the number of 
successful coping strategies. Moreover, at follow-up, 
patients appeared to be bothered significantly less by 
the secondary gastrointestinal complaints flatulence 
[p = .01), abdominal rumbling (p = .003), and 
difficult or painful defecation [p = .01) as noted in 
the diary compared with pretreatment. Between pre­
treatment and follow-up, the DAC score decreased 
with an average of 23% (SD = 58). The more the 
DAC score decreased, the less patients reported 
using medication for abdominal complaints (r —
TABLE 2. Mean Scores on Complaints, Daily Avoidance, 
Number of Successful Coping Strategies, and Psychological 
Well Being at Pretreatment and Follow-Up [N  = 32) with Level 







DAC score 5.60 (3.25) 3.91 (3.36) .005
Daily duration 11.47 (7,75) 8.72 (8.37) .039
Dally avoidance 2 1 . 2 2  (30.20) 13.11 (27.86) .035
Inventory
Severity score 5,06(1 .99) 4.34 (2.56) .091
Number of successful 2,12 (1.79) 3.09 (2.75) .037
coping strategies
Psychological well 149 (45.90) 145 (56.42) ,39
being
«n n _____ j ?___________ __ ^  te»  * *a The prescheduled diary was completed by 27 patients.
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-.44, p = .01) and consulting their general practitio- group treatment has long term effects. Analyzing the 
ner for abdominal complaints at follow-up [r = - specific nature of the coping strategies revealed that 
doing relaxation exercises was not the only success­
ful strategy, as was suggested in an earlier study (32). 
More positive cognitions and emotions, such as 
score appeared to be clinically improved. In addi- “worrying less/’ “getting angry less frequently/1 and
.43, 
p -  .01).
Using the criterion for clinical improvement of 
50% decrease, in 37% of the patients, the DAC
tion, the following gastrointestinal complaints were 
clinically improved in at least half of the patients
“thinking that the pain will decrease,” appeared to 
have a favorable influence on the abdominal com-
who were bothered by that complaint: flatulence plaints, too. Apparently, comparable with earlier
(reported by 23 patients of which 57% clinically findings (12, 20), changes in abdominal complaints
improved), belching (reported by 16 patients of are associated with changes in thoughts and behav-
which 63% clinically improved), nausea (reported iors,
by 16 patients of which 50% clinically improved), Besides the favorable treatment results mentioned
heartburn (reported by 11 patients of which 73% above, our study has some methodological assets,
clinically improved), and abdominal rumbling (re- too. First, in this study, patients rated their abdom-
ported by 23 patients of which 65% clinically im- inai complaints four times daily, whereas in other
proved). No differences emerged in comparing the studies complaints were either rated only once-per-
follow-up results of former controls and first-treated day (13—20, 22, 32-34) or were not assessed at all by
patients and in the comparison of the results of self-observation (21). Moreover, patients in this
female and male patients. study not only rated their abdominal pain and type
Short vs. Long Term Follow-Up. As there is a of defecation through daily self-observation but also 
considerable range in the duration of the follow-up, five other gastrointestinal complaints associated 
we investigated whether the treatment outcome dif- with irritable bowel syndrome. Most abdominal
symptoms occur erratically throughout the day (35), 
so we believe that assessing complaints four times 
daily is more valid than assessing complaints once- 
revealed no differences in any of the outcome mea- per-day. A consequence of this assessment differ-
fered between patients with a shorter and a longer 
duration of follow-up. Comparing patients with ^1 
year (N  = 9) and >1 year (N  = 23) follow-up
sures nor did comparing patients with ^2  years [N 
17) and >2 years (N  = 15) follow-up.
= enee is that the clinical outcome of our study cannot 
be compared with that found by others. Second, in 
contrast to other studies, the present study evaluated 
a rather large patient sample {N = 43) using a 
controlled design and a long term follow-up. Other 
studies evaluating group therapy for patients with 
The results of the present study indicate that a IBS either were uncontrolled, used self-selected pa- 
cognitive-behavioral group treatment is more effec- tients or only small samples, or only investigated 
tive in alleviating irritable bowel syndrome than a short term effects (21, 22).
DISCUSSION
waiting period without intervention. Cognitive-be- The present study fulfilled a number of Klein’s
havioral group treatment not only improved the stringent criteria necessary for a satisfactory treat- 
daily observed intensity and duration of the com- ment trial in irritable bowel syndrome (10). The 
plaints but also reduced patients’ daily avoidance 
behavior and increased the number of successful
study used clear entry criteria and demographic 
features to establish the generalizability of the re-
cognitive and behavioral coping strategies. It may be suits, adequate sample sizes, valid statistical tech- 
assumed that this is a direct result of the treatment, niques, a treatment trial of sufficient length (3 
which aimed at restructuring patients5 complaint- months), baseline comparisons between conditions,
related cognitions and behavior. and relevant outcome measures. Nevertheless, this
The improvement found at posttreatment ap- study had methodological limitations. The first
peared to be maintained at follow-up; an average of shortcoming is the not strict random allocation. A
more than 2 years after completion of the group period of allocation to the experimental group was
treatment, the abdominal complaints were still im- followed by a period of allocation to the waiting list
proved compared with the pretreatment levels. and so on. A consequence of a complete random
Moreover, patients still used more successful coping design would have been that the patients in the
strategies than before treatment. We could not find waiting list had to wait a long time before treatment
any difference between a short and a long term could be offered to them. Despite this lack of proper
follow-up, so it may be concluded that our brief randomization, our experimental and control group
512 Psychosomatic Medicine 58:508-514 (1996)
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appeared to be similar with respect to baseline control group, or altering the size of the groups. The 
measures and as a consequence were considered to group treatment we offered consisted of only eight 
be well matched. Therefore, we believe that this 
shortcoming has not distorted our findings»
Furthermore, an attention placebo control group 
would have been a better comparison. In psychother­
apy research, however, it is very difficult to provide 
proper attention placebo treatment. Also, the thera­
pist can seldom or never be blinded. We saw im-
therapy sessions, less than the number of sessions 
offered by others (22). Although our short term 
treatment appeared to have long term effects, it is 
still possible that more sessions would increase the
effectiveness of the treatment.
As a result of the broad criteria we used in defin­
ing irritable bowel syndrome, our results, strictly
provements in the number of coping strategies and speaking, can be generalized reliably only to the
in the avoidance behavior corresponding with the subgroup of broadly defined abdominal pain-pre-
aixn of the treatment, so it is less probable that these dominant refractory outpatients with irritable bowel
positive results arose just because patients were syndrome. Yet, gastrointestinal complaints associ-
given attention, regardless of its nature. ated with restrictively defined irritable bowel syn-
Moreover, we investigated the short term effects of drome were also found to improve during follow-up,
cognitive-behavioral group treatment in a controlled so the present results can possibly be generalized to
trial. In investigating the long term effects, no wait- this group of patients, too.
ing list control group was used because waiting to Remarkably, patients1 psychological well being
start treatment for an average of 2 years was believed did not appear to improve as a result of the group
to be unethical. Patients could have improved re- treatment. However, improvement in psychological
gardless of the followed treatment. However, the well being appeared to be related to improvement in
prognosis of irritable bowel syndrome is known to be abdominal complaints. Results of a cross-lagged
poor (7-9). In this light, our results can considered to panel analysis (38) confirmed that the level of pa-
be positive. It would increase the impact of our tients’ psychological well being is a consequence of
findings if future studies could prove the long term the daily observed intensity of the abdominal com-
superiority of cognitive-behavioral group treatment plaints rather than a precursor, consistent with the
over the natural course or usual care for patients
with IBS.
One could furthermore argue that we should have
results of an earlier study that found that physical 
health had a positive effect on mental health (38, 39), 
Short term cognitive-behavioral group treatment
adjusted our a-level for the number of comparisons appears to have a long term effectiveness in allevi-
^ (36, 37). Yet, following the purpose of the treatment 
offered, we expected to find differences in a re­
stricted number of six outcome measures. Even if we
ating abdominal complaints of referred patients w ith 
severe and chronic IBS. Therefore, doctors are rec­
ommended to refer their patients with refractory IBS
would have adjusted our a-level, significant im- at an early stage to cognitive-behavioral therapy.
provements in Daily Abdominal Complaint score 
and daily avoidance would continue to exist.
Finally, in the present study, IBS was defined 
¿ broadly, based on the Rome criteria (5), as abdominal 
] pain with or without disordered defecation not ex­
plained by any structural or biochemical abnormal­
ities; all patients in this study appeared to suffer 
from abdominal pain with or without disordered 
defecation. In the more restrictive definition of IBS 
(6), abdominal pain and disordered defecation must 
both be present. For that reason, in studies on 
patients with restrictive IBS treatment, outcome is 
evaluated on the basis of changes in pain and  con­
stipation and/or diarrhea (22). In agreement with our 
definition of IBS, we calculated a reduction score 
based on changes in abdominal pain only, without 
taking into account possible disordered defecation.
The clinical outcome of cognitive-behavioral 
group therapy might improve further by prolonging 
the treatment, assessing long term effects using a
This study was funded by the Centre for Women 's 
Studies, University o f Nijmegen, The Netherlands.
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